ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. (Q45993642)

18 December 2017

title

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. (English)

1 reference

18 December 2017

1 reference

1 reference

18 December 2017

Pertti J. Neuvonen

1 reference

18 December 2017

Mikko Niemi

1 reference

18 December 2017

author name string

J E Keskitalo

1 reference

18 December 2017

M F Fromm

1 reference

18 December 2017

K J Kurkinen

1 reference

18 December 2017

language of work or name

English

0 references

publication date

27 May 2009

1 reference

18 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

197-203

1 reference

18 December 2017

SLCO1B1 variants and statin-induced myopathy--a genomewide study

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Role of OATP transporters in the disposition of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Functional analysis of SNPs variants of BCRP/ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Importance of P-glycoprotein at blood-tissue barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Lipid-lowering response to statins is affected by CYP3A5 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

ATP-binding cassette transporters in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.79

1 reference

18 December 2017

1 reference

18 December 2017